SLNO Operating Cash Flow (Statement)
Soleno Therapeutics Inc · Operating Cash Flow (Statement)
SLNO Operating Cash Flow (Statement)
Latest reported$105.71Mperiod ending
SLNO Cash from Operations (-$3.50M → $105.71M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SLNO operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 46,798,000 | |
| -69,096,000 | |
| -24,940,000 | |
| -20,781,000 | |
| -27,770,000 | |
| -25,224,000 | |
| -17,375,000 | |
| -11,683,000 | |
| -9,949,958 | |
| -13,497,980 | |
| -10,299,330 | |
| -4,484,362 | |
| -885,218 | |
| -3,496,432 |